FIELD: medicine.
SUBSTANCE: on week 7-8, blood is examined, the resistance of factor Va to activated protein C (APS-resistance) is determined by the normalized ratio (NR). With its value of 0.49 and below the risk of PE development is predicted.
EFFECT: improved prediction accuracy.
1 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF SEVERE PREECLAMPSIA IN PREGNANT WOMEN ACCOMPANYING A MUTATION OF THE PROTHROMBIN GENE, GENOTYPE F2G20210A | 2019 |
|
RU2723627C1 |
METHOD OF PREECLAMPSIA PREVENTION IN PREGNANT WOMEN WITH MUTATION OF FACTOR V LEIDEN 1691 G/A | 2017 |
|
RU2666251C1 |
METHOD FOR PREVENTION OF PREECLAMPSIA IN CARRIERS OF F2G20210A MUTATION WITH SUPERTHRESHOLD INCREASE OF PROTHROMBIN ACTIVITY | 2019 |
|
RU2712444C1 |
METHOD FOR PREDICTION OF THROMBOEMBOLIC COMPLICATIONS IN WOMEN ACCOMPANYING PROTROMBIN GENE MUTATIONS [F2(20210)GA] | 2019 |
|
RU2722280C1 |
METHOD FOR PREDICTION OF RISK OF MALIGNANT GROWTHS IN FEMALE GENITAL ORGANS AND MAMMARY GLANDS | 2014 |
|
RU2578459C1 |
METHOD OF PROTEIN C ACTIVATOR PREPARING | 2000 |
|
RU2184976C1 |
METHOD OF DIAGNOSIS OF THROMBOPHILIA DETERMINED BY RESISTANCE OF FACTOR V TO ACTIVATED PROTEIN C | 2001 |
|
RU2205411C2 |
METHOD FOR CONTROL OF SUBSTITUTIONAL THERAPY EFFICIENCY AT DVS- SYNDROME | 2000 |
|
RU2190855C2 |
METHOD FOR DIAGNOSING ANTIPHOSPHOLIPID SYNDROME | 2000 |
|
RU2186391C2 |
METHOD FOR PREDICTION OF RISK OF DEGREE 2-3 CHRONIC PLACENTAL INSUFFICIENCY WITH FOETAL GROWTH DELAY SYNDROME IN PREGNANT WOMEN | 2013 |
|
RU2540928C1 |
Authors
Dates
2017-11-21—Published
2016-11-14—Filed